The Medial Meniscus is a known secondary stabilizer to the ACL in terms of anterior tibial translation in the knee. So what happens after ACL reconstruction if the medial meniscus is deficient? Dr. Andrew Fithian, MD joins us to discuss his study addressing this very question. Coming to us from Kaiser Permanente San Diego, Dr. Fithian and his team investigated postoperative anterior tibial translation in autograft ACL patients with an intact medial meniscus, a repaired medial meniscus, or a partially resected medial meniscus. The results may guide decision making when facing a situation with an irreparable medial meniscus tear in the setting of an ACL tear, particularly with graft choice.

As another exciting NFL season kicks off, Sports Medicine community members and fans alike continue to ponder whether the risk of lower extremity injury is higher on artificial turf versus grass. We welcome UCSF’s Chief of Sports Medicine & Shoulder Surgery and host of the podcast 6-8 Weeks: Perspectives on Sports Medicine, Dr. Brian Feeley, MD to discuss his team’s recent publication in OJSM examining this very question. 

Historically, ACL repair resulted in poor outcomes and this procedure fell out of favor while ACL reconstruction became the gold-standard surgical approach for a torn ACL. Recently, thanks in part to the advent of more modern techniques, ACL repair has regained interest in the Sports Medicine community as a potentially viable option in certain situations that may provide advantages in comparison to ACL reconstruction. To this point, the literature comparing these two surgeries with modern techniques has been heterogenous in terms of quality and design, and results have been mixed. Drs. Kyle Kunze, MD and Benedict Nwachukwu, MD, MBA and their team from Hospital of Special Surgery (HSS) bring us this systematic review and meta-analysis to cull the best literature available. Their findings indicate that, while ACL repair may have an evolving role in our toolbox, its failure rate remains higher than that of ACL reconstruction and thus should be approached with caution.

One of the long-standing assumptions in Sports Medicine is that anterosuperior labral variants including the Buford Complex and Sublabral Foramen are non-pathologic, normal anatomic variants of the shoulder joint.  But is this true?  Dr. Eric Edmonds from Rady Children’s Hospital in San Diego challenges this assumption and our accepted practice of ignoring these findings when observed arthroscopically.

Failure of shoulder stabilization surgery continues to plague contact athletes. Football players are thus at high risk of a repeat shoulder dislocation even after a well-done surgery to stabilize that joint. Such is the nature of a sport with violent and unpredictable collisions. Dr. Andrew Pennock, MD and his team at Rady Children’s in San Diego investigated the outcomes for high school football players who underwent arthroscopic stabilization surgery. They anticipated finding that the younger the player at the time of surgery, the higher risk of recurrence throughout his high school career. What they didn’t anticipate finding was that a high percentage of players who opted not to return to football did so because of fear. While we have seen this fear factor impact athletes after ACL reconstruction, the magnitude of this effect in this population was surprising.

Second ACL injuries, whether it be a tear of the ipsilateral ACL graft or the native contralateral ACL, continue to be of great concern to patients and sports medicine practitioners particularly during the first 1-2 years after surgery. Sending a patient back too early to play is widely considered a major risk factor for this 2nd injury. As health care providers, we take pride in the joy and confidence a patient expresses as he/she advances through a rehab process towards his/her goals. However, when it comes to ACL reconstruction rehab, overconfidence may put the patient at risk, and perhaps slow and steady wins the race. We welcome Dr. Takehiko Matsushita, MD, PhD from Kobe University in Japan to discuss his study investigating the relationship between psychological readiness to return to sport and the risk of a 2nd ACL injury. His findings show that the biggest favor we can do for a patient who accelerates through the ACL recovery period quickly and confidently may be to slow him/her down.

The right surgery for recurrent patellofemoral instability remains a topic of controversy.  While medial patellofemoral ligament reconstruction (MPFLr) is the standby surgical procedure for this condition, many adjuncts including tibial tubercle osteotomy (TTO) are performed concurrently with the hope of improving the chances of success.  Historically, a tibial tubercle-trochlear groove (TT-TG) distance greater than 20 mm has triggered surgeons to perform TTO, however recent evidence suggests this may be unnecessarily aggressive.  We welcome Dr. Mininder Kocher, MD, MPH from Boston Children’s and Harvard Medical School to discuss his study evaluating the outcomes of MPFLr alone versus MPFLr + TTO in patients with recurrent patellofemoral instability with a tibial tubercle-trochlear groove (TT-TG) distance greater than 20 mm.

Despite our technological advances in ACL surgery, the rehabilitation period remains challenging, particularly when it comes to lingering quadriceps weakness. Blood Flow Restriction (BFR) Therapy has been introduced as a potential means to speed up the return of quad function. We welcome Dr. Kelechi Okoroha from the Mayo Clinic to discuss his high-level study, “Effects of Perioperative Blood Flow Restriction Therapy Program on Early Quadriceps Strength and Patient-Reported Outcomes After Anterior Cruciate Ligament Reconstruction.” By utilizing BFR in both the pre- and post-operative periods following ACL reconstruction, Dr. Okoroha and his team did demonstrate a benefit in strength and patient reported outcomes.

Proper treatment of Type III AC Joint Separations has been a topic of ongoing debate. In OJSM’s August edition, Drs. Mark Tauber, Phillipp Moroder and their team from the German Shoulder Center in Munich, Germany, published, “Prospective Multicenter Randomized Controlled Trial of Surgical Versus Nonsurgical Treatment of Acute Rockwood Type 3 Acromioclavicular Injury,” a high-level study that showed no difference in outcomes between surgical and nonsurgical management of this injury. We are joined by two of the finest surgeons in California’s Central Valley, Shoulder/Elbow Specialist Dr. Julia Lee, MD from Sierra Pacific Orthopedics and Traumatologist Dr. JT Christensen, MD from Kaiser Permanente to discuss this study and share their insights and practices.